Prostate Cancer

Prostate Cancer

The prostate is a small gland, roughly 3-4 cm in size, sitting just below the urinary bladder and wrapped around the upper part of the urethra. Because of this location, even a small change within it can affect urine flow. Prostate cancer tends to grow slowly in many individuals. Some tumours remain confined within the gland for years without causing harm. Others behave differently, more aggressive, spreading beyond the capsule into nearby tissues or even to bones.

It is essential that regular screening be done when required. We usually consider screening in:

  • Men above 50 years
  • Those above 45 with a family history
  • Patients with persistent urinary symptoms

The PSA (Prostate-Specific Antigen) test is a simple blood test. But it is not perfect. PSA can rise not only in cancer, but also in benign enlargement or even infection. So, an elevated value, say above 4 ng/mL, doesn’t automatically mean cancer. It prompts further evaluation.

We often combine PSA with a digital rectal examination (DRE), where the prostate is gently assessed through the rectal wall. It takes less than a minute, though patients are understandably hesitant at first.

Early prostate cancer is often silent. No pain, no clear warning signs. Many cases are picked up incidentally during routine tests. When confined to the prostate, within its outer capsule, it is usually more manageable, sometimes even monitored without immediate treatment. Advanced disease behaves differently. The cancer may extend beyond the gland, involving nearby structures or spreading to bones, commonly the lower spine, pelvis, or ribs. At this stage, symptoms begin to appear, and treatment becomes more complex.

Symptoms, when they occur, are often gradual and overlapping with benign conditions.

Urinary symptoms:

  • Difficulty starting urination
  • Weak or interrupted stream
  • Increased frequency, especially at night
  • Feeling of incomplete bladder emptying

Other concerning signs:

  • Blood in urine or semen
  • Persistent lower back or hip pain (possible bone involvement)
  • Unexplained weight loss in later stages
  • Erectile dysfunction in some cases

Consult doctors for further evaluation at the best prostate cancer hospital in Navi Mumbai, UMC Hospitals.

Treatment depends on multiple factors: stage, PSA levels, tumour grade, age, and overall health. There is no single standard path.

For early, low-risk cancers:

  • Active surveillance
    • Regular PSA monitoring
    • Periodic scans or biopsies
    • No immediate intervention unless progression is seen
  • For localised disease:
    • Surgery (prostate removal) in selected cases
    • Radiation therapy
      • External beam radiation over several sessions
      • Sometimes combined with hormone therapy
  • Other treatment approaches:
    • Hormone therapy: reduces testosterone, which fuels cancer growth
    • Cryoablation: freezing cancer tissue in specific cases
    • Chemotherapy: usually for advanced or resistant disease
    • Targeted therapy / Immunotherapy: in selected advanced cases

We provide a combination of all treatment options to manage prostate cancer.

Reach out to oncologists at our hospital for the best services for radiation, targeted therapy, and prostate cancer surgery in Navi Mumbai.

Our team of highly trained and experienced oncologists provides personalized diagnosis and care for prostate cancer. It includes:

  • Interpreting PSA trends over time rather than a single value
  • Correlating imaging findings with biopsy results
  • Explaining clearly whether the cancer is low-risk, intermediate, or aggressive
  • Discussing benefits and side effects, particularly urinary control and sexual function

Some patients may not need immediate treatment and are monitored safely for years. Others require timely intervention. Both approaches are valid when chosen appropriately. If you are over 50 and have never discussed prostate health, you must get it checked. Consult doctors at the best oncology hospital in Navi Mumbai, UMC Hospitals for further assistance.